Tight transcriptional control of foreign genes introduced into the germline of transgenic mice would be of great experimental value in studies of gene function. To develop a system in which the spatial and temporal expression of candidate genes implicated in cardiac development or function could be tightly controlled in vivo, we have generated transgenic mice expressing a tetracycline-controlled transactivator (tTA) under the control of a rat alpha myosin heavy chain promoter (MHC alpha-tTA mice), as well as mice harboring a candidate target gene implicated in the control of differentiation, Id1 (tet-Id1 mice). No expression of the target transgene was detected in any tissues of hemizygous tet-Id1 mice. Genetic crosses with MHC alpha-tTA mice resulted in transactivation of the Id1 transgene, but expression was restricted to heart, where tTA was expressed. Furthermore, transactivation of the target gene was tightly and reversibly controlled by systemic therapy with tetracycline, both in utero and postnatally. These studies demonstrate the feasibility of such a binary approach for tightly controlling the timing and extent of expression of transgenes in vivo. This approach should be generally useful for the ectopic expression of candidate genes in selected tissues during delineated developmental stages.
R S Passman, G I Fishman
Title and authors | Publication | Year |
---|---|---|
Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy.
Eriksson RAE, Nieminen T, Galibert L, Peltola SK, Tikkanen P, Käyhty P, Lesch HP, Ylä-Herttuala S, Airenne KJ |
Frontiers in Medicine | 2022 |
Doxycycline-inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat) as an HIV/neuroAIDS model
D Langford, B oh Kim, W Zou, Y Fan, P Rahimain, Y Liu, JJ He |
Journal of Neurovirology | 2017 |
Cardiomyocyte Overexpression of FABP4 Aggravates Pressure Overload-Induced Heart Hypertrophy
J Zhang, C Qiao, L Chang, Y Guo, Y Fan, L Villacorta, YE Chen, J Zhang, X Cheng |
PloS one | 2016 |
p53 and p16Ink4a/p19Arf Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells
S Azzopardi, S Pang, DS Klimstra, YC Du |
Neoplasia (New York, N.Y.) | 2016 |
Gene Therapy
S Nimesh |
Gene Therapy | 2013 |
Adult Stem Cells
K Turksen |
Adult Stem Cells | 2013 |
Cardiac-specific inducible and conditional gene targeting in mice
T Doetschman, M Azhar |
Circulation research | 2012 |
Cardiac-Specific Expression of the Tetracycline Transactivator Confers Increased Heart Function and Survival Following Ischemia Reperfusion Injury
L Elsherif, X Wang, M Grachoff, BM Wolska, DL Geenen, JP O'Bryan |
PloS one | 2012 |
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz |
Protein Engineering for Therapeutics Part B | 2012 |
Cardiac-Specific Expression of the Tetracycline Transactivator Confers Increased Heart Function and Survival Following Ischemia Reperfusion Injury
L Elsherif, X Wang, M Grachoff, BM Wolska, DL Geenen, JP O'Bryan, F Martelli |
PloS one | 2012 |
FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model
TG Schips, A Wietelmann, K Hohn, S Schimanski, P Walther, T Braun, T Wirth, HJ Maier |
Cardiovascular Research | 2011 |
Conditional expression of constitutively active phosphatase-1-inhibitor-1 improves cardiac contractility in young mice but is deleterious after catecholaminergic stress and with aging
Katrin Wittköpper, Larissa Fabritz, Stefan Neef, Katarina Ort, Clemens Grefe, Bernhard Unsöld, Paulus Kirchhof, Lars Maier, Gerd Hasenfuss, Dobromir Dobrev, Thomas Eschenhagen, Ali El-Armouche |
Journal of Clinical Investigation | 2010 |
microRNA-208a is a regulator of cardiac hypertrophy and conduction
Thomas E. Callis, Kumar Pandya, Hee Young Seok, Ru-Hang Tang, Mariko Tatsuguchi, Zhan-Peng Huang, Jian-Fu Chen, Zhongliang Deng, Bronwyn Gunn, Janelle Shumate, Monte S. Willis, Craig H. Selzman, Da-Zhi Wang |
Journal of Clinical Investigation | 2009 |
Activation of PyMT in beta cells induces irreversible hyperplasia, but oncogene-dependent acinar cell carcinomas when activated in pancreatic progenitors
YC Du, DS Klimstra, H Varmus |
PloS one | 2009 |
A new mouse model for temporal- and tissue-specific control of extracellular superoxide dismutase
Y Zou, CH Chen, JR Fike, TT Huang |
genesis | 2009 |
Gene regulation technologies in zebrafish
H Esengil, JK Chen |
Molecular BioSystems | 2008 |
Spatial and temporal down-regulation of transgene expression using the TRSID-silencer in mice: Application to Prnp
M Gallozzi, V Béringue, P Decaunes, AL Dur, KL Roux, G Tilly, SL Guillou, L Herzog, C Peyre, A Ladroue, J Chapuis, M Vilotte, B Passet, J Costa, N Chenais, FL Provost, H Laude, JL Vilotte |
FEBS Letters | 2008 |
Conditional Mutagenesis: An Approach to Disease Models
R Feil, D Metzger |
Handbook of experimental pharmacology | 2007 |
Conditional expression of a myocardium-specific transgene in zebrafish transgenic lines
CJ Huang, TS Jou, YL Ho, WH Lee, YT Jeng, FJ Hsieh, HJ Tsai |
Developmental Dynamics | 2005 |
Conditional overexpression of transgenes in megakaryocytes and platelets in vivo
HG Nguyen, G Yu, M Makitalo, D Yang, HX Xie, MR Jones, K Ravid |
Blood | 2005 |
Molecular Cardiology
Z Sun |
2005 | |
Transgenic Models in Pharmacology
S Offermanns, L Hein |
2004 | |
Encyclopedia of Cell Technology
NL Parenteau |
Encyclopedia of Cell Technology | 2003 |
Recent advances in inducible expression in transgenic mice
C Albanese, J Hulit, T Sakamaki, RG Pestell |
Seminars in Cell & Developmental Biology | 2002 |
Tetracycline-controlled transcriptional regulation systems: advances and application in transgenic animal modeling
Z Zhu, T Zheng, CG Lee, RJ Homer, JA Elias |
Seminars in Cell & Developmental Biology | 2002 |
Gene Therapy of Cancer
IV Lebedeva, CA Stein |
Gene Therapy of Cancer | 2002 |
Use of Genetically Engineered Mice in Drug Discovery and Development: Wielding Occam's Razor to Prune the Product Portfolio
B Bolon, E Galbreath |
International Journal of Toxicology | 2002 |
Oxygen tension and a pharmacological switch in the regulation of transgene expression for gene therapy
E Payen, M Bettan, A Henri, E Tomkiewitcz, A Houque, I Kuzniak, J Zuber, D Scherman, Y Beuzard |
The Journal of Gene Medicine | 2001 |
A novel strategy for regulated expression of a cytotoxic gene
YM Bi, SJ Rothstein, AG Wildeman |
Gene | 2001 |
Heart Physiology and Pathophysiology
NS Dhalla, RM Temsah, T Netticadan, MS Sandhu |
Heart Physiology and Pathophysiology | 2001 |
Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor
M Komatsu, S Jepson, ME Arango, CA Carraway, KL Carraway |
Oncogene | 2001 |
Tetracyclines in Biology, Chemistry and Medicine
M Nelson, W Hillen, RA Greenwald |
2001 | |
A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects
Y Dor, TD Camenisch, A Itin, GI Fishman, JA McDonald, P Carmeliet, E Keshet |
Development (Cambridge, England) | 2001 |
Remodeling the Cardiac Sarcomere Using Transgenesis
J Robbins |
Annual Review of Physiology | 2000 |
The Laboratory Rat
H Schulz, H Muhle |
The Laboratory Rat | 2000 |
Antisense Transgenics in Animals
RP Erickson |
Methods | 1999 |
Gene Expression Systems
R Abbud, JH Nilson |
Gene Expression Systems | 1999 |
Temporal, spatial and cell type–specific control of Cre-mediated DNA recombination in transgenic mice
AR Utomo, AY Nikitin, WH Lee |
Nature Biotechnology | 1999 |
Targeted Expression of a Dominant-Negative K v 4.2 K + Channel Subunit in the Mouse Heart
AD Wickenden, P Lee, R Sah, Q Huang, GI Fishman, PH Backx |
Circulation research | 1999 |
A novel RU486 inducible system for the activation and repression of genes
SS Chua, Y Wang, FJ DeMayo, BW O'Malley, SY Tsai |
Advanced Drug Delivery Reviews | 1998 |
INDUCIBLE GENE EXPRESSION IN THE NERVOUS SYSTEM OF TRANSGENIC MICE
JR Gingrich, J Roder |
Annual Review of Neuroscience | 1998 |
Conditional lineage ablation to model human diseases
P Lee, G Morley, Q Huang, A Fischer, S Seiler, JW Horner, S Factor, D Vaidya, J Jalife, GI Fishman |
Proceedings of the National Academy of Sciences | 1998 |
Timing Is Everything in Life: Conditional Transgene Expression in the Cardiovascular System
GI Fishman |
Circulation research | 1998 |
Mammary Gland Transgenesis
FO Castro, J Jänne |
1998 | |
Intermittent, Repetitive Corticosteroid-Induced Upregulation of Platelet Levels After Adenovirus-Mediated Transfer to the Liver of a Chimeric Glucocorticoid-Responsive Promoter Controlling the Thrombopoietin cDNA
K Narumi, M Suzuki, W Song, MA Moore, RG Crystal |
Blood | 1998 |
Expression of protein kinase C beta in the heart causes hypertrophy in adult mice and sudden death in neonates
JC Bowman, SF Steinberg, T Jiang, DL Geenen, GI Fishman, PM Buttrick |
Journal of Clinical Investigation | 1997 |
Strategic gene transfer into the kidney: Current status and prospects
M Kitamura |
Clinical and Experimental Nephrology | 1997 |
Modulation of Erythropoietin Delivery from Engineered Muscles in Mice
D Bohl, JM Heard |
Human Gene Therapy | 1997 |
Inducible gene expression in mammalian cells and transgenic mice
E Saez, D No, A West, RM Evans |
Current Opinion in Biotechnology | 1997 |
Progress in Transcriptionally Targeted and Regulatable Vectors for Genetic Therapy
N Miller, J Whelan |
Human Gene Therapy | 1997 |
Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblasts
D Bohl, N Naffakh, JM Heard |
Nature Medicine | 1997 |
Pharmacochemistry Library
D Andisik, P Bernstein, F Brown, C Bryant, C Ceccarelli, J Damewood, P Edwards, S Feeney, B Gomes, R Green, B Kosmider, A Shaw, G Steelman, R Thomas, P Tuthill, E Vacek, C Veale, P Warner, J Williams, D Wolanin, S Woolson |
Pharmacochemistry Library | 1997 |
Lack of gradual regulation of tetracycline-controlled gene expression by the tetracyclin-repressor/VP16 transactivator (tTA) in cultured cells
C Hop, V Waard, JA van Mourik, H Pannekoek |
FEBS Letters | 1997 |
Use of Transgenic Mice in Aging Research
A Richardson, AR Heydari, WW Morgan, JF Nelson, ZD Sharp, CA Walter |
ILAR journal / National Research Council, Institute of Laboratory Animal Resources | 1997 |
Molecular remodeling of cardiac contractile function
J James, J Robbins |
American journal of physiology. Heart and circulatory physiology | 1997 |
Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice
N Schultze, Y Burki, Y Lang, U Certa, H Bluethmann |
Nature Biotechnology | 1996 |
Creation of a reversible on/off system for site-specific in vivo control of exogenous gene activity in the renal glomerulus
M Kitamura |
Proceedings of the National Academy of Sciences | 1996 |
Bi-directional gene switching with the tetracycline repressor and a novel tetracycline antagonist
J Chrast-Balz, RH van Huijsduijnen |
Nucleic Acids Research | 1996 |
Diverse strategies for tetracycline-regulated inducible gene expression
PE Shockett, DG Schatz |
Proceedings of the National Academy of Sciences | 1996 |
Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice
A Kistner, M Gossen, F Zimmermann, J Jerecic, C Ullmer, H Lübbert, H Bujard |
Proceedings of the National Academy of Sciences | 1996 |
Inducible gene expression from defective herpes simplex virus vectors using the tetracycline-responsive promoter system
DY Ho, JR McLaughlin, RM Sapolsky |
Molecular Brain Research | 1996 |
Fast large-scale purification of tetracycline repressor variants from overproducing Escherichia coli strains
N Ettner, G Müller, C Berens, H Backes, D Schnappinger, T Schreppel, K Pfleiderer, W Hillen |
Journal of Chromatography A | 1996 |
Conditional Transgene Expression in the Heart
Z Yu, CS Redfern, GI Fishman |
Circulation research | 1996 |
Transgenic Models of Human Viral and Immunological Disease
FV Chisari, MB Oldstone |
1996 | |
Reversible Intercellular Coupling by Regulated Expression of a Gap Junction Channel Gene
GI Fishman, Y Gao, EL Hertzberg, DC Spray |
Cell Communication and Adhesion | 1995 |
Conditional transgenics
GI Fishman |
Trends in Cardiovascular Medicine | 1995 |